Bellevue Life Sciences Acquisition Corp. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net income was USD 0.301464 million compared to net loss of USD 0.000988 million a year ago. Basic earnings per share from continuing operations was USD 0.03. Diluted earnings per share from continuing operations was USD 0.03.
For the six months, net income was USD 0.411769 million compared to net loss of USD 0.001114 million a year ago. Basic earnings per share from continuing operations was USD 0.06. Diluted earnings per share from continuing operations was USD 0.06.